Telos Biotech Inc., 2025-12-12
An SEC Form D private-offering notice from Dallas, TX, a $2,250,000 filer-stated offering target in Biotech. Filed 2025-12-12. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Develops Telovance, a protein complex delivered during cell therapy manufacturing to lengthen shortened telomeres and improve the durability of engineered cells.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- FibroBiologics, Inc., 2025-12-16, $1.7M, Houston, TX
- Prospyr Medical, Inc., 2025-12-16, $13.6M, Austin, TX
- Novilytic, LLC, 2025-12-15, $1M, West Lafayette, IN
- Tutis Group, Inc., 2025-12-15, $5M, Dallas, TX
- Consano Bio, Inc., 2025-12-12, $16.8M, Burlington, MA
- Glydr Galactic Holdings Inc, 2025-12-10, Plano, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.